ArticleAnnals of surgical oncology2023

ASO Author Reflections: Risk for Three-Course Neoadjuvant Chemotherapy in Advanced Esophageal Cancer.

Yuto Kubo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.